SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank33
3Y CAGR-11.3%
5Y CAGR-3.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-11.3%/yr
Annual compound
5Y CAGR
-3.6%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.50M | +18.0% |
| 2024 | $8.90M | -84.3% |
| 2023 | $56.57M | +275.9% |
| 2022 | $15.05M | -54.7% |
| 2021 | $33.21M | +163.3% |
| 2020 | $12.61M | +98.7% |
| 2019 | $6.35M | - |